Benzodiazepines and antidepressants: Effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia

Objectives: We aim to study the effects of the prescription of benzodiazepines and antidepressants on cognitive and functional decline in older adults living with Alzheimer's disease (AD) and Lewy body dementia (LBD) over a 5‐year follow‐up. Methods: This is a longitudinal analysis of a Norwegi...

Full description

Autores:
Borda, Miguel Germán
Jaramillo-Jimenez, Alberto
Oesterhus, Ragnhild
Santacruz, José Manuel
Tovar Ríos, Diego Alejandro
Soennesyn, Hogne
Cano-Gutierrez, Carlos
Vik-Mo, Audun Osland
Aarsland, Dag
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Universidad Autónoma de Occidente
Repositorio:
RED: Repositorio Educativo Digital UAO
Idioma:
eng
OAI Identifier:
oai:red.uao.edu.co:10614/13923
Acceso en línea:
https://hdl.handle.net/10614/13923
https://red.uao.edu.co/
Palabra clave:
Estudio caso-control
Case-control method
Activities of daily living
Alzheimer's disease
Antidepressive Agent
Benzodiazepines
Cognitive decline
Dementia
Functional disability
Hypnotics and sedatives
Lewy body dementia
Rights
openAccess
License
Derechos Reservados International Journal of Geriatric Psychiatry
Description
Summary:Objectives: We aim to study the effects of the prescription of benzodiazepines and antidepressants on cognitive and functional decline in older adults living with Alzheimer's disease (AD) and Lewy body dementia (LBD) over a 5‐year follow‐up. Methods: This is a longitudinal analysis of a Norwegian cohort study entitled “The Dementia Study of Western Norway” (DemVest). We included 196 patients newly diagnosed with AD (n = 111) and LBD (n = 85), followed annually for 5 years. Three prescription groups were defined: only benzodiazepines (BZD), only antidepressants (ADep), and the combination of benzodiazepines and antidepressants (BZD‐ADep). Linear mixed‐effects models were conducted to analyze the effect of the defined groups on the outcomes. The outcomes were functional decline, measured by the Rapid Disability Rating Scale—2, and cognition measured with the Mini‐Mental State Examination. Results: Prescription of the combination of benzodiazepines and antidepressants in LBD was associated with faster functional decline. In AD, the prescription of BZD and BZD‐ADep was associated with greater functional deterioration. ADep alone did not show positive or negative significant associations with the studied outcomes. Conclusions: BZD and especially the combination of BZD and ADep are associated with functional decline in AD and LBD and should be used cautiously